Effect of Platelet Rich Fibrin (PRF) on Peri-implant Soft Tissue and Crestal Bone in One-Stage Implant Placement: A Randomized Controlled Trial

Boora, Priyanka; Rathee, Manu; Bhoria, Mohaneesh

doi:10.7860/jcdr/2015/12636.5788

Cited by 59 publications

(81 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Osseointegration process (Table 2ba): n = 3, (Boora, Rathee, & Bhoria, 2015; Öncü & Alaaddinoglu, 2015; Tabrizi, Arabion, & Karagah, 2017). …”

Section: Resultsmentioning

confidence: 99%

“…PRF reduced marginal bone loss (Boora et al., 2015). Furthermore, ISQ values were increased after 1 and 4 weeks in the PRF group (Öncü & Alaaddinoglu, 2015) and after 2, 4, and 6 weeks in the posterior maxilla (Tabrizi et al., 2017).…”

Section: Resultsmentioning

confidence: 99%

“…Furthermore, ISQ values were increased after 1 and 4 weeks in the PRF group (Öncü & Alaaddinoglu, 2015) and after 2, 4, and 6 weeks in the posterior maxilla (Tabrizi et al., 2017). Clinical parameters such as probing depth and bleeding on probing as well as implant survival did not change upon PRF treatment compared to control (Boora et al., 2015). …”

Section: Resultsmentioning

confidence: 99%

“…This implies that PRF might enhance implant stability during the early phase of osseointegration. Another study showed less marginal bone loss with PRF (Boora et al., 2015). However, this data is limited to implants with a follow‐up of 3 months.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

The use of platelet‐rich fibrin to enhance the outcomes of implant therapy: A systematic review

Strauß

Stähli

Gruber

2018

Clinical Oral Implants Res

105

View full text Add to dashboard Cite

ObjectiveTo assess the impact of platelet‐rich fibrin (PRF) on implant dentistry. The primary focused question was as follows: What are the clinical, histological, and radiographic outcomes of PRF administration for bone regeneration and implant therapy?MethodA systematic literature search comprised three databases: MEDLINE, EMBASE, and Cochrane followed by a hand search of relevant scientific journals. Human studies using PRF for bone regeneration and implant therapy were considered and articles published up to December 31, 2017 were included. Eligible studies were selected based on the inclusion criteria. Randomized controlled trials (RCT) and controlled clinical trials (CCT) were included.ResultsIn total, 5,963 titles were identified with the search terms and by hand search. A total of 12 randomized controlled trials (RCT) met the inclusion criteria and were chosen for data extraction. Included studies focused on alveolar ridge preservation after tooth extraction, osseointegration process, soft tissue management, bone augmentation, bone regeneration after sinus floor elevation and surgical peri‐implantitis treatment. Overall, the risk of bias was moderate or unclear. Nine studies showed superior outcomes for PRF for any of the evaluated variables, such as ridge dimension, bone regeneration, osseointegration process, soft tissue healing. Three studies failed to show any beneficial effects of PRF. No meta‐analysis could be performed due to the heterogeneity of study designs.ConclusionsThere is moderate evidence supporting the clinical benefit of PRF on ridge preservation and in the early phase of osseointegration. It remains unclear whether PRF can reduce pain and improve soft tissue healing. More research support is necessary to comment on the role of PRF to improve other implant therapy outcomes.

show abstract

“…Osseointegration process (Table 2ba): n = 3, (Boora, Rathee, & Bhoria, 2015; Öncü & Alaaddinoglu, 2015; Tabrizi, Arabion, & Karagah, 2017). …”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The use of platelet‐rich fibrin to enhance the outcomes of implant therapy: A systematic review

Strauß

Stähli

Gruber

2018

Clinical Oral Implants Res

105

View full text Add to dashboard Cite

show abstract

“…[2,3] The tissue healing have been observed to be improved with the concomitant use of Platelet Rich-Fibrin (PRF). [4] In the present case, early placement of endosseous dental implant treated with Platelet Rich-Fibrin has been used in maxillary esthetic zone in a young adult patient to promote bone healing and osseointegration. complaint of missing upper front tooth for past one week and wanted replacement of the same.…”

Section: Introductionmentioning

confidence: 92%

Esthetic and Functional Rehabilitation through Early Placement of PRF Augmented Dental Implant in Maxillary Aesthetic Zone

Rathee¹,

Khanna²,

Yadav³

2016

AIMDR

View full text Add to dashboard Cite

Implants placed shortly after tooth extraction have proven to be a predictable treatment modality. The number of surgical appointments and length of surgical phase are reduced, thereby preserving hard and soft tissue configuration. However, there are some limitations to early implant placement. These include a probable lack of soft tissue closure over the extraction site, difficulty in matching the diameter of the implant with that of the extraction socket, partially or totally missing bony housings, and possible accompanying periapical and/or periodontal infection.This clinical report presentsearly dental implant placement with PRF augmentation in maxillary esthetic zone.

show abstract

Autologous blood products: Usage and preparation protocols

Palaiologou

Keeling

2022

Clin Adv Periodontics

View full text Add to dashboard Cite

Focused clinical question What are the appropriate preparation protocols for autologous blood products to support their clinical utilization? Summary Autologous blood products provide a unique clinical benefit. Their popularity among the professions is growing. However, as this is a rapidly evolving field, multiple modalities are presented within the literature. Frequently there is no demonstrated superiority to previous iterations. This brief review attempts to offer a concise chronology on their evolution, preparation, and where possible, evidence to support their clinical utilization. Conclusions The field of autologous blood products is expanding rapidly. These products appear to yield variable clinical benefits in specific indications. However, evidence supporting their universal application is scant, and the superiority of one formulation versus another is yet to be demonstrated.

show abstract

Effect of Platelet Rich Fibrin (PRF) on Peri-implant Soft Tissue and Crestal Bone in One-Stage Implant Placement: A Randomized Controlled Trial

Cited by 59 publications

References 12 publications

The use of platelet‐rich fibrin to enhance the outcomes of implant therapy: A systematic review

The use of platelet‐rich fibrin to enhance the outcomes of implant therapy: A systematic review

Esthetic and Functional Rehabilitation through Early Placement of PRF Augmented Dental Implant in Maxillary Aesthetic Zone

Autologous blood products: Usage and preparation protocols

Contact Info

Product

Resources

About